Titleist Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Titleist Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$427K	Sell	1,568 -94	-6%	-$24.4K	0.03%	309
2026 Q2	$412K	Sell	1,662 -25	-1%	-$5.38K	0.03%	300
2026 Q1	$339K	Buy	1,687 +30	+2%	+$6.21K	0.03%	309
2025 Q4	$342K	Buy	+1,657	New	+$331K	0.03%	287

Other funds holding FBT

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

JWS

Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return

FEG

Financial Enhancement Group Anderson, Indiana $871M AUM 12.19% 1-Year Est. Return

GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.5B AUM 13.03% 1-Year Est. Return

DQRIM

Dale Q Rice Investment Management Vancouver, Washington $184M AUM 55.8% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

SFGP

Stonebridge Financial Group (Pennsylvania) Wormleysburg, Pennsylvania $1.36B AUM 14.31% 1-Year Est. Return

HAG

HF Advisory Group Annapolis, Maryland $336M AUM 14.9% 1-Year Est. Return

DWMS

Dominguez Wealth Management Solutions Williamsburg, Virginia $181M AUM 16.39% 1-Year Est. Return

Titleist Asset Management's FBT Position: Q3 2026 in Review

Titleist Asset Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 5.7% in Q3 2026, selling an estimated $24.4K and leaving 1,568 shares worth $427K. The position accounts for 0.03% of the portfolio, ranked #309.

Titleist Asset Management first reported a position in FBT in Q4 2025 and has held it in 4 quarters since. 22 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

Titleist Asset Management held 1,568 shares of First Trust NYSE Arca Biotechnology Index Fund worth $427K as of Q3 2026.
Titleist Asset Management sold 94 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $24.4K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Titleist Asset Management's portfolio in Q3 2026, its #309 holding.
Titleist Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2025 and has held it in 4 quarters since.
22 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Titleist Asset Management's 13F filing for Q3 2026, filed 8 Oct 2026.